The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that causes the novel coronavirus disease 2019 (COVID-19), is highly transmissible and pathogenic for humans and may cause life-threatening disease and mortality, especially in individuals with underlying comorbidities. First identified in an outbreak in Wuhan, China, COVID-19 is affecting more than 185 countries and territories around the world, with more than 15,754,651 confirmed cases and more than 640,029 deaths. Since December 2019, SARS-CoV-2 transmission has become a global threat, which includes confirmed cases in all 50 states within the United States (US). As of 25 July 2020, the Johns Hopkins Whiting School of Engineering Center for Systems Science and Engineering reports more than 4,112,651 cases and 145,546 deaths. To date, health disparities are associated with COVID-19 mortality among underserved populations. Here, the author explores potential underlying reasons for reported disproportionate, increased risks of mortality among African Americans and Hispanics/Latinos with COVID-19 compared with non-Hispanic Whites. The author examines the underlying clinical implications that may predispose minority populations and the adverse clinical outcomes that may contribute to increased risk of mortality. Government and community-based strategies to safeguard minority populations at risk for increased morbidity and mortality are essential. Underserved populations living in poverty with limited access to social services across the US are more likely to have underlying medical conditions and are among the most vulnerable. Societal and cultural barriers for ethnic minorities to achieve health equity are systemic issues that may be addressed only through shifts in governmental policies, producing long-overdue, substantive changes to end health care inequities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“, the most common comorbidities associated with adverse clinical outcomes in COVID-19 patients were hypertension (30%), diabetes (19%), and coronary heart disease (8%) [43].”
BackgroundHoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · cited 1×
“If corticosteroid therapy is recommended for COVID-19 patients, glucose levels should be monitored carefully to avoid pulmonary and immune dysfunction [50,51] (Figure 1).”
BackgroundWu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
Rothan, H. A., & Byrareddy, S. N. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102433 · Cited by 5,840
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341 · cited 1×
“However, it is known that SARS-CoV-2 binds to the ACE2 receptor, mainly in the lung, to enter cells [45,46].”
BackgroundYang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 6×
“describes the clinical course of the first 799 critically ill COVID-19 patients admitted to an isolation ward in Wuhan, China [26].”
BackgroundInfluentialHui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109 · cited 1×
“The β-CoV lineages HCoV-OC43 and HCoV-HKU1 typically are associated with self-limiting upper respiratory infections in immunocompetent hosts and occasionally lower respiratory tract infections in immunocompromised hosts and the elderly [13,14].”
BackgroundCOVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19
Vaduganathan, M., Vardeny, O., Michel, T., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2020) · New England Journal of Medicine · doi:10.1056/nejmsr2005760 · Cited by 2,101
Pan, A., Liu, L., Wang, C., Guo, H., Hao, X., Wang, Q., Huang, J., He, N., Yu, H., Lin, X., et al. (2020) · JAMA · doi:10.1001/jama.2020.6130 · Cited by 1,931
COVID-19 and cardiovascular disease
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046941 · Cited by 1,738
Woo, P. C. Y., Lau, S. K. P., Lam, C. S. F., Lau, C. C. Y., Tsang, A. K. L., Lau, J. H. N., Bai, R., Teng, J. L. L., Tsang, C. C. C., Wang, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06540-11 · Cited by 1,677
Covid-19: risk factors for severe disease and death
Jordan, R. E., Adab, P., & Cheng, K. K. (2020) · BMJ · doi:10.1136/bmj.m1198 · Cited by 1,653 · cited 1×
“Populations at higher risk for COVID-19 are more likely to become ill, need critical care, including mechanical ventilation, and die of the disease [23].”
BackgroundZhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579
Woo, P. C. Y., Lau, S. K. P., Chu, C.-M., Chan, K.-H., Tsoi, H.-W., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W.-K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.884-895.2005 · Cited by 1,525
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Zhang, T., Wu, Q., & Zhang, Z. (2020) · Current Biology · doi:10.1016/j.cub.2020.03.022 · Cited by 1,397
Vasan, R. S., Beiser, A., Seshadri, S., Larson, M. G., Kannel, W. B., D'Agostino, R. B., & Levy, D. (2002) · JAMA · doi:10.1001/jama.287.8.1003 · Cited by 1,388
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256 · cited 1×
“CoVs cause respiratory, enteric, hepatic, and neurological diseases in various animal species, including camels, cattle, cats, and bats [11,12].”
BackgroundSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
Kuiken, T., Fouchier, R. A., Schutten, M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., Laman, J. D., de Jong, T., van Doornum, G., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13967-0 · Cited by 1,020
The International Committee on Taxonomy of Viruses
Murphy, F. A., Fauquet, C. M., Bishop, D. H. L., Ghabrial, S. A., Jarvis, A. W., Martelli, G. P., Mayo, M. A., & Summers, M. D. (1995) · Virus Taxonomy · doi:10.1007/978-3-7091-6607-9_3 · Cited by 944
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
Oudit, G. Y., Kassiri, Z., Jiang, C., Liu, P. P., Poutanen, S. M., Penninger, J. M., & Butany, J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02153.x · Cited by 893
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233147 · Cited by 858
Leung, J. M., Yang, C. X., Tam, A., Shaipanich, T., Hackett, T.-L., Singhera, G. K., Dorscheid, D. R., & Sin, D. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.00688-2020 · Cited by 845
Yang, J. K., Feng, Y., Yuan, M. Y., Yuan, S. Y., Fu, H. J., Wu, B. Y., Sun, G. Z., Yang, G. R., Zhang, X. L., Wang, L., et al. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01861.x · Cited by 794
Zhao, Q., Meng, M., Kumar, R., Wu, Y., Huang, J., Lian, N., Deng, Y., & Lin, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25889 · Cited by 724
The COVID-19 pandemic: a call to action to identify and address racial and ethnic disparities
Laurencin, C. T., & McClinton, A. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00756-0 · Cited by 682
Tikellis, C., & Thomas, M. C. (2012) · International Journal of Peptides · doi:10.1155/2012/256294 · Cited by 624
Interspecies transmission and emergence of novel viruses: lessons from bats and birds
Chan, J. F.-W., To, K. K.-W., Tse, H., Jin, D.-Y., & Yuen, K.-Y. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.005 · Cited by 616
Racial and ethnic differences in cardiovascular disease risk factors: a systematic review.
Kurian, A. K., & Cardarelli, K. (2007) · PubMed · doi:10.13016/rsqw-ztls · Cited by 556
Treatment options for COVID-19: The reality and challenges
Jean, S.-S., Lee, P.-I., & Hsueh, P.-R. (2020) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.034 · Cited by 518
Copeland, K. C., Zeitler, P., Geffner, M., Guandalini, C., Higgins, J., Hirst, K., Kaufman, F. R., Linder, B., Marcovina, S., McGuigan, P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1642 · Cited by 464
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
Batlle, D., Wysocki, J., & Satchell, K. (2020) · Clinical Science · doi:10.1042/cs20200163 · Cited by 444
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm.
Bassetti, M., Vena, A., & Giacobbe, D. R. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13209 · Cited by 423
Disparities in Diabetes: The Nexus of Race, Poverty, and Place
Gaskin, D. J., Thorpe, R. J., McGinty, E. E., Bower, K., Rohde, C., Young, J. H., LaVeist, T. A., & Dubay, L. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301420 · Cited by 417
Lanting, L. C., Joung, I. M. A., Mackenbach, J. P., Lamberts, S. W. J., & Bootsma, A. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2280 · Cited by 386
Acute and chronic complications of type 2 diabetes mellitus in children and adolescents
Pinhas-Hamiel, O., & Zeitler, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60821-6 · Cited by 385
Outbreak of a novel coronavirus
Du Toit, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0332-0 · Cited by 374
Geographic Distribution of Diagnosed Diabetes in the U.S.
Barker, L. E., Kirtland, K. A., Gregg, E. W., Geiss, L. S., & Thompson, T. J. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.12.019 · Cited by 319
McBean, A. M., Li, S., Gilbertson, D. T., & Collins, A. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2317 · Cited by 304
Singh, A. K., Majumdar, S., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.054 · Cited by 252
Maddocks, M., Lovell, N., Booth, S., Man, W. D.-C., & Higginson, I. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32127-x · Cited by 222
Defining and targeting health disparities in chronic obstructive pulmonary disease
Pleasants, R., Riley, I., & Mannino, D. (2016) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s79077 · Cited by 202
Ferdinand, K. C., Yadav, K., Nasser, S. A., Clayton‐Jeter, H. D., Lewin, J., Cryer, D. R., & Senatore, F. F. (2017) · The Journal of Clinical Hypertension · doi:10.1111/jch.13089 · Cited by 190
Commentary: COVID-19 in patients with diabetes
Hill, M. A., Mantzoros, C., & Sowers, J. R. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154217 · Cited by 183
Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium
KLINGENSMITH, G. J., Connor, C. G., Ruedy, K. J., Beck, R. W., Kollman, C., Haro, H., Wood, J., Lee, J. M., Willi, S. M., Cengiz, E., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12281 · Cited by 141
Adams, M. L., Katz, D. L., & Grandpre, J. R. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.200679 · Cited by 133
A current review of COVID-19 for the cardiovascular specialist
Lang, J. P., Wang, X., Moura, F. A., Siddiqi, H. K., Morrow, D. A., & Bohula, E. A. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.04.025 · Cited by 123
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
Klonoff, D. C., & Umpierrez, G. E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154224 · Cited by 105
Schraufnagel, D. E., Blasi, F., Kraft, M., Gaga, M., Finn, P. W., & Rabe, K. F. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1509st · Cited by 100
1. Strategies for Improving Care
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s004 · Cited by 96
Social Determinants of Health and Racial/Ethnic Disparities in Type 2 Diabetes in Youth
Butler, A. M. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0885-0 · Cited by 94
Ren, Z., Hu, R., Wang, Z., Zhang, M., Ruan, Y., Wu, Z., Wu, H., Hu, X.-P., Hu, Z., Ren, W., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.008 · Cited by 80
Ethnic Disparities in Adherence to Antihypertensive Medications of Medicare Part D Beneficiaries
Holmes, H. M., Luo, R., Hanlon, J. T., Elting, L. S., Suarez-Almazor, M. E., & Goodwin, J. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04037.x · Cited by 79
Ritchey, M., Chang, A., Powers, C. A., Loustalot, F. V., Schieb, L. J., Ketcham, M., Durthaler, J. M., & Hong, Y. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6536e1 · Cited by 77
Management of Essential Hypertension
Ferdinand, K. C., & Nasser, S. A. (2017) · Cardiology Clinics · doi:10.1016/j.ccl.2016.12.005 · Cited by 74
Bimonte, S., Crispo, A., Amore, A., Celentano, E., Cuomo, A., & Cascella, M. (2020) · In Vivo · doi:10.21873/invivo.11949 · Cited by 71
Yilin, Z., Yandong, N., & Jin, F. (2015) · Burns · doi:10.1016/j.burns.2015.04.010 · Cited by 64
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses
Fraussen, J., Claes, N., Wijmeersch, B. V., van Horssen, J., Stinissen, P., Hupperts, R., & Somers, V. A. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.10.001 · Cited by 62
[Asthma and COPD management during the COVID-19 pandemic].
Daccord, C., Touilloux, B., & von Garnier, C. (2020) · PubMed · Cited by 14
Cited by
Cancer statistics for the US Hispanic/Latino population, 2021
Miller, K. D., Ortiz, A. P., Pinheiro, P. S., Bandi, P., Minihan, A., Fuchs, H. E., Martinez Tyson, D., Tortolero‐Luna, G., Fedewa, S. A., Jemal, A. M., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21695 · Cited by 398
COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans
Kricorian, K., & Turner, K. (2021) · PLOS ONE · doi:10.1371/journal.pone.0256122 · Cited by 161
Stephenson-Hunter, C., Franco, S., Martinez, A., & Strelnick, A. H. (2021) · Health Equity · doi:10.1089/heq.2021.0060 · Cited by 19
Campbell, R., Javorka, M., Engleton, J., Goodman-Williams, R., & Gregory, K. (2023) · Journal of Interpersonal Violence · doi:10.1177/08862605221098963 · Cited by 6
“Incidents of gender-based violence have also increased during the pandemic (Piquero et al., 2020), so it is critical to understand how victim service programs have been affected, particularly in communities of Color.”
BackgroundInfluential
Metadata
- Authors
- Alcendor, D. J.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2020-07-30
- Volume
- 9
- Issue
- 8
- Pages
- 2442
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W3045622115
- Cited by
- 332
- References
- 79
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.